Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for biomedical research and in vitro drug testing. Our new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enables customers to emulate multiple organs, deliver and test drugs in a
standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates). SeedEZ scaffold is a universal 3D cell culture screening system that enables scientists to grow cells in 3D to simulate living tissues, test compounds, and assess function with improved physiological relevance. SeedEZ is compliant with medium- to high-throughput screening assays and high content screening assays for both target-based and phenotypic drug discovery. Lena Biosciences GradientEZ system is a convenient 3D framework for 3D cell migration, invasion, chemotaxis and chemo-invasion assays. Lena Biosciences is a privately-held life sciences company with operations in Atlanta, GA. The company was founded in 2008 as a spin-off from the Georgia Institute of Technology. The company’s innovative technologies have been vetted by grant awards from the National Institutes of Health, National Science Foundation and the Georgia Research Alliance. For more information about Lena Biosciences, please visit its website at http://www.lenabio.com
